Nanalysis Chosen by IMRIS as Critical Component MRI Supplier
Nanalysis Scientific Corp. (OTCQX: NSCIF) has secured a significant five-year OEM supplier and technology licensing agreement with IMRIS Imaging, Inc., a leader in intraoperative MRI. The non-exclusive agreement includes an upfront payment and builds upon a previous 12-month contract.
The partnership leverages Nanalysis's core electronics and software technology platform, which is utilized across their benchtop NMR, high-field NMR, and MRI products. IMRIS has validated Nanalysis's MRI console during system prototyping, positioning the company as a critical component supplier for IMRIS's integrated operating suites.
Nanalysis Scientific Corp. (OTCQX: NSCIF) ha stipulato un importante accordo quinquennale non esclusivo come fornitore OEM e per la licenza tecnologica con IMRIS Imaging, Inc., specializzata in risonanza magnetica intraoperatoria. L'intesa prevede un pagamento iniziale e si basa su un contratto precedente di 12 mesi.
La collaborazione sfrutta la piattaforma tecnologica di elettronica e software di Nanalysis, impiegata nelle loro apparecchiature NMR da banco, NMR ad alto campo e prodotti MRI. IMRIS ha convalidato la console MRI di Nanalysis durante la prototipazione del sistema, rendendo l'azienda un fornitore chiave per le sale operatorie integrate di IMRIS.
Nanalysis Scientific Corp. (OTCQX: NSCIF) ha alcanzado un importante acuerdo no exclusivo de cinco años como proveedor OEM y de licencia tecnológica con IMRIS Imaging, Inc., líder en MRI intraoperatoria. El acuerdo incluye un pago inicial y se apoya en un contrato previo de 12 meses.
La alianza aprovecha la plataforma tecnológica central de Nanalysis —electrónica y software— utilizada en sus productos de RMN de sobremesa, RMN de alto campo y MRI. IMRIS validó la consola MRI de Nanalysis durante la prototipación del sistema, posicionando a la compañía como proveedor clave para las salas integradas de IMRIS.
Nanalysis Scientific Corp. (OTCQX: NSCIF)는 수술 중 MRI 분야의 선두업체인 IMRIS Imaging, Inc.와 5년간의 비독점 OEM 공급 및 기술 라이선스 계약을 체결했습니다. 이 계약에는 선급금이 포함되며, 이전의 12개월 계약을 기반으로 확장된 것입니다.
이번 파트너십은 Nanalysis의 핵심 전자 및 소프트웨어 플랫폼을 활용하며, 해당 플랫폼은 벤치톱 NMR, 고자장 NMR 및 MRI 제품 전반에 사용됩니다. IMRIS는 시스템 프로토타이핑 과정에서 Nanalysis의 MRI 콘솔을 검증하여, IMRIS 통합 수술실을 위한 핵심 부품 공급업체로서의 위치를 확립했습니다.
Nanalysis Scientific Corp. (OTCQX: NSCIF) a conclu un accord non exclusif important de cinq ans en tant que fournisseur OEM et de licence technologique avec IMRIS Imaging, Inc., spécialiste de l'IRM intra‑opératoire. L'accord prévoit un paiement initial et s'appuie sur un contrat préalable de 12 mois.
Le partenariat s'appuie sur la plateforme technologique centrale d'électronique et de logiciels de Nanalysis, utilisée sur leurs produits RMN de paillasse, RMN haute intensité et MRI. IMRIS a validé la console MRI de Nanalysis lors de la conception du prototype système, faisant de la société un fournisseur clé pour les salles d'opération intégrées d'IMRIS.
Nanalysis Scientific Corp. (OTCQX: NSCIF) hat mit IMRIS Imaging, Inc., einem führenden Anbieter intraoperativer MRT, eine bedeutende nicht-exklusive OEM-Liefer- und Technologie-Lizenzvereinbarung über fünf Jahre abgeschlossen. Die Vereinbarung beinhaltet eine Vorauszahlung und baut auf einem vorherigen 12-monatigen Vertrag auf.
Die Partnerschaft nutzt Nanalysis' zentrale Elektronik- und Softwareplattform, die in ihren Tisch-NMR-, Hochfeld-NMR- und MRT-Produkten eingesetzt wird. IMRIS hat die MRI-Konsole von Nanalysis während der Systemprototypenvalidierung bestätigt und macht das Unternehmen damit zu einem wichtigen Komponentenlieferanten für IMRIS’ integrierte Operationssäle.
- Secured five-year OEM supplier and technology licensing agreement with IMRIS
- Agreement includes immediate upfront payment with medium-term revenue potential
- Technology validation from a leading intraoperative MRI company
- Demonstrates successful cross-application of technology across NMR and MRI products
- Agreement is non-exclusive, allowing IMRIS to potentially work with other suppliers
"We are very proud of our relationship with IMRIS, a leader in intraoperative MRI that provides optimized, fully integrated operating suites that address the important needs of patients, clinicians, and hospitals," says Sean Krakiwsky, Nanalysis Scientific Corp. CEO. "The non-exclusive agreement we are announcing provides some immediate cash and some larger, medium-term revenue potential. The core electronics and software being licensed are also used in our benchtop NMR and high-field NMR products, which are sold around the world. This deal is emblematic of how our MRI and NMR businesses reinforce one another to create scalable, global growth opportunities. "
Nanalysis CTO, Julien Muller, says: "My vision has been to develop a technology platform that is feasible for benchtop NMR, high-field NMR and MRI. The fundamental math and physics are largely the same across many types of magnetic resonance applications, and value is optimized by adopting such a strategy. This deal validates our technology platform strategy of leveraging our core electronics and software for different types of magnetic resonance applications where image quality and speed are paramount. We have been working with IMRIS for about a year and with their magnet subsidiary for over a decade. We are excited about our future together."
Marc Buntaine, IMRIS CEO, states, "We have a very rigorous process to vet critical component suppliers and have been very impressed by Julien and the Nanalysis team. Their MRI console has allowed us to be successful during system prototyping, and we are confident that Nanalysis Scientific Corp. is the right partner as we continue development and progress toward commercialization."
About Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA:1N1)
Nanalysis Scientific Corp. develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers used worldwide in pharma, biotech, energy, food, materials, and security industries, as well as in academic and government labs. The Company also operates a growing services division that maintains both its own products and third-party imaging equipment, anchored by a
About IMRIS Imaging, Inc.
As a leader in image guidance solutions, IMRIS Imaging, Inc., provides optimized, fully integrated image-guided therapy environments that address the important needs of patients, clinicians, and hospitals by delivering timely MRI and imaging data to clinicians for use during surgical or interventional procedures. The IMRIS Operating Suite enables intraoperative imaging directly within operating rooms. IMRIS also designs and manufactures proprietary head fixation devices, imaging coils and OR tables for use in this unique and multifunctional intraoperative environment. IMRIS products are sold globally to clinical centers in the neurosurgical, spinal, cardiovascular and orthopedic markets. It is estimated that over 70,000 patients have benefited from lifesaving or life-extending procedures performed in an IMRIS Operating Suite. Additional information about IMRIS is available at www.imris.com.
Notice regarding Forward Looking Statements and Legal Disclaimer
This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.
View original content to download multimedia:https://www.prnewswire.com/news-releases/nanalysis-chosen-by-imris-as-critical-component-mri-supplier-302544890.html
SOURCE Nanalysis Scientific Corp.
FAQ
What is the new partnership between Nanalysis Scientific Corp (NSCIF) and IMRIS?
How will the IMRIS agreement benefit Nanalysis Scientific Corp (NSCIF)?
What technology is Nanalysis (NSCIF) providing to IMRIS?
How long is the licensing agreement between Nanalysis (NSCIF) and IMRIS?
What makes IMRIS an important partner for Nanalysis Scientific Corp (NSCIF)?
